Jonczyk A - Search Results

1

Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy.

DeNardo SJ, Burke PA, Leigh BR, O'Donnell RT, Miers LA, Kroger LA, Goodman SL, Matzku S, Jonczyk A, Lamborn KR, DeNardo GL. DeNardo SJ, et al. Among authors: jonczyk a. Cancer Biother Radiopharm. 2000 Feb;15(1):71-9. doi: 10.1089/cbr.2000.15.71. Cancer Biother Radiopharm. 2000. PMID: 10740655

2

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Storgard CM, et al. Among authors: jonczyk a. J Clin Invest. 1999 Jan;103(1):47-54. doi: 10.1172/JCI3756. J Clin Invest. 1999. PMID: 9884333 Free PMC article.

3

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.

Dechantsreiter MA, Planker E, Mathä B, Lohof E, Hölzemann G, Jonczyk A, Goodman SL, Kessler H. Dechantsreiter MA, et al. Among authors: jonczyk a. J Med Chem. 1999 Aug 12;42(16):3033-40. doi: 10.1021/jm970832g. J Med Chem. 1999. PMID: 10447947

4

In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.

Mitjans F, Meyer T, Fittschen C, Goodman S, Jonczyk A, Marshall JF, Reyes G, Piulats J. Mitjans F, et al. Among authors: jonczyk a. Int J Cancer. 2000 Sep 1;87(5):716-23. Int J Cancer. 2000. PMID: 10925366

5

Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation.

Kantlehner M, Schaffner P, Finsinger D, Meyer J, Jonczyk A, Diefenbach B, Nies B, Hölzemann G, Goodman SL, Kessler H. Kantlehner M, et al. Among authors: jonczyk a. Chembiochem. 2000 Aug 18;1(2):107-14. doi: 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.0.CO;2-4. Chembiochem. 2000. PMID: 11828404

6

alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.

Nisato RE, Tille JC, Jonczyk A, Goodman SL, Pepper MS. Nisato RE, et al. Among authors: jonczyk a. Angiogenesis. 2003;6(2):105-19. doi: 10.1023/B:AGEN.0000011801.98187.f2. Angiogenesis. 2003. PMID: 14739617

7

RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways.

Castel S, Pagan R, Mitjans F, Piulats J, Goodman S, Jonczyk A, Huber F, Vilaró S, Reina M. Castel S, et al. Among authors: jonczyk a. Lab Invest. 2001 Dec;81(12):1615-26. doi: 10.1038/labinvest.3780375. Lab Invest. 2001. PMID: 11742032 Free article.

8

Definition of an unexpected ligand recognition motif for alphav beta6 integrin.

Kraft S, Diefenbach B, Mehta R, Jonczyk A, Luckenbach GA, Goodman SL. Kraft S, et al. Among authors: jonczyk a. J Biol Chem. 1999 Jan 22;274(4):1979-85. doi: 10.1074/jbc.274.4.1979. J Biol Chem. 1999. PMID: 9890954 Free article.

9

Transmembrane-truncated alphavbeta3 integrin retains high affinity for ligand binding: evidence for an 'inside-out' suppressor?

Mehta RJ, Diefenbach B, Brown A, Cullen E, Jonczyk A, Güssow D, Luckenbach GA, Goodman SL. Mehta RJ, et al. Among authors: jonczyk a. Biochem J. 1998 Mar 1;330 ( Pt 2)(Pt 2):861-9. doi: 10.1042/bj3300861. Biochem J. 1998. PMID: 9480902 Free PMC article.

10

Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.

Patsenker E, Popov Y, Stickel F, Jonczyk A, Goodman SL, Schuppan D. Patsenker E, et al. Among authors: jonczyk a. Gastroenterology. 2008 Aug;135(2):660-70. doi: 10.1053/j.gastro.2008.04.009. Epub 2008 Apr 16. Gastroenterology. 2008. PMID: 18538673 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters